J Frontier has revised the pricing structure of its online medical consultation platform “SOKUYAKU” and announced earnings forecasts for 2027-05. The revision is expected to expand revenue and profit, with operating income projected to reach approximately \u00a51,050 million in the fiscal year ending May 2027.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2934","jir_company_name":"J Frontier Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-21","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/2934-20260721-01.pdf","jir_short_summary":"J Frontier has revised the pricing structure of its online medical consultation platform \"SOKUYAKU\" and announced earnings forecasts for 2027-05. The revision is expected to expand revenue and profit, with operating income projected to reach approximately \u00a51,050 million in the fiscal year ending May 2027.","jir_summary":"### Performance Overview\nJ Frontier revised the fee structure of its online consultation and medication guidance platform \"SOKUYAKU,\" establishing new initial and monthly usage fees. This change aims to promote contract expansion and increase recurring revenue, with consolidated operating income in the fiscal year ending May 2027 expected to significantly exceed previous plans, reaching approximately \u00a51,050 million. The revision is driven by efforts to enhance the customer success system and improve system functionalities through system upgrades, with minimal additional costs.\n\n### Future Outlook and Impact\nSupported by the revised pricing structure and deregulation trends, the SOKUYAKU business is expected to continue high sales growth over the medium term. Projected sales indexation starting from FY2024-05 is 116, expected to reach 150 in FY2025-05, with actual figures for FY2026-05. The company plans to maintain growth beyond 2027 and build a stable revenue base as the digitalization of the healthcare and pharmacy industries advances.","jir_financial_highlights":"Consolidated Operating Income for FY2027-05: \u00a51,050 million (YoY +236.2%)\nFY2026-05 Full-Year Financial Results Operating Income: Unknown (Unknown)","jir_category":"","jir_hashtags":"#JFrontier, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Consolidated Operating Income for FY2027-05: \u00a51,050 million (forecast)\nSales Indexation for FY2026-05: 150 (actual)\nSales Indexation for FY2024-05: 100 (actual)","jir_meta_title":"\u3010J Frontier\u3011Profit Expansion in Online Medical Consultation Business\uff5c2026-07","jir_meta_description":"J Frontier announced a revision of the \"SOKUYAKU\" pricing structure and earnings forecast. Operating income is expected to reach approximately \u00a51,050 million in FY2027-05, demonstrating business expansion and profit growth.","jir_og_title":"\u3010J Frontier\u3011Forecasted Profit Expansion for SOKUYAKU Business\uff5c2026-07","jir_og_description":"J Frontier announced revisions to pricing and a mid-term growth outlook. Operating income is projected to reach approximately \u00a51,050 million in FY2027-05, aiming for business expansion.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59459,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-85745","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n